Long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes.
about
Long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Long-term safety and efficacy ...... patients with type 2 diabetes.
@en
Long-term safety and efficacy ...... patients with type 2 diabetes.
@nl
type
label
Long-term safety and efficacy ...... patients with type 2 diabetes.
@en
Long-term safety and efficacy ...... patients with type 2 diabetes.
@nl
prefLabel
Long-term safety and efficacy ...... patients with type 2 diabetes.
@en
Long-term safety and efficacy ...... patients with type 2 diabetes.
@nl
P2093
P2860
P356
P1476
Long-term safety and efficacy ...... patients with type 2 diabetes
@en
P2093
Genki Kaneko
Kazuoki Kondo
Kenichi Nishimura
Maki Gouda
Nobuhiro Nakanishi
Nobuko Maruyama
Nobuya Inagaki
Takashi Kadowaki
Yumi Watanabe
P2860
P356
10.1111/DOM.13038
P577
2017-07-31T00:00:00Z